Imaging in Cancer Clinical Trials

Improving Assessment Quality and Workflows through Quantitative Standardization

Imaging in clinical trials has grown by 700 percent since 2001, becoming an important—and often primary— component as an endpoint or surrogate endpoint in cancer clinical trial designs. Despite the potential benefits, the uptick in use of specific imaging-based endpoints has exposed challenges associated with clinical trial workflows and protocol standardization.

Fill out the form to download our latest whitepaper, Imaging in Cancer Clinical Trials, to learn workflow strategies that standardize and bring efficiencies to this important aspect of oncology care.

Please fill out the form below to access the white paper